Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

作者: Claudia A. Dumitru , Agnes Bankfalvi , Xiang Gu , Wilfried E. Eberhardt , Reinhard Zeidler

DOI: 10.3389/FIMMU.2013.00033

关键词:

摘要: CORTACTIN is an actin-binding protein critically involved in cellular migration and invasion. Here, we investigated the role of pathophysiology orohypopharynx carcinoma – one major subtypes head neck cancer. To this end, analysed expression tumor tissues from 89 patients relation to clinical parameters. We found that high tumoral associated with poor survival, higher T-stage lymph node metastasis (N-stage) these patients. Next, combined prognostic values stromal cell biological parameters our patient cohort. determined potential interaction tumor-infiltrating neutrophils, which have been previously linked outcome advanced disease. Interestingly, both neutrophilic infiltration had significantly worse than all other These findings suggest neutrophils might be functionally during progression carcinoma. In vitro, showed released soluble factors phosphorylated cells promoted their migration. Furthermore, demonstrated strong phosphorylation correlated Taken together, unravel a novel mechanism tumor-stroma interaction, relevant for more accurate prognosis improved therapeutic strategies entity.

参考文章(27)
Trine O. Jensen, Henrik Schmidt, Holger J. Møller, Frede Donskov, Morten Høyer, Pia Sjoegren, Ib J. Christensen, Torben Steiniche, Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer. ,vol. 118, pp. 2476- 2485 ,(2012) , 10.1002/CNCR.26511
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
H. Nozawa, C. Chiu, D. Hanahan, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 12493- 12498 ,(2006) , 10.1073/PNAS.0601807103
P Hofman, C Butori, K Havet, V Hofman, E Selva, N Guevara, J Santini, E Van Obberghen-Schilling, Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status British Journal of Cancer. ,vol. 98, pp. 956- 964 ,(2008) , 10.1038/SJ.BJC.6604245
Xu-Zhi Xu, Marileila Varella Garcia, Tian-yu Li, Li-Yan Khor, R Sujatha Gajapathy, Cindy Spittle, Scott Weed, Stuart R Lessin, Hong Wu, Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Modern Pathology. ,vol. 23, pp. 187- 196 ,(2010) , 10.1038/MODPATHOL.2009.157
Amanda Gatesman Ammer, Scott A. Weed, Cortactin branches out: Roles in regulating protrusive actin dynamics Cell Motility and the Cytoskeleton. ,vol. 65, pp. 687- 707 ,(2008) , 10.1002/CM.20296
JP Rodrigo, D García-Carracedo, LA García, ST Menéndez, E Allonca, MV González, MF Fresno, C Suárez, JM García-Pedrero, Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas The Journal of Pathology. ,vol. 217, pp. 516- 523 ,(2009) , 10.1002/PATH.2462
Giueng-Chueng Wang, Po-Shiuan Hsieh, Hsian-He Hsu, Guang-Huan Sun, Shin Nieh, Cheng-Ping Yu, Jong-Shiaw Jin, Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness World Journal of Urology. ,vol. 27, pp. 557- 563 ,(2009) , 10.1007/S00345-009-0376-2
Claudia A. Dumitru, Katrin Moses, Sokratis Trellakis, Stephan Lang, Sven Brandau, Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology Cancer Immunology, Immunotherapy. ,vol. 61, pp. 1155- 1167 ,(2012) , 10.1007/S00262-012-1294-5
Marius Ilie, Véronique Hofman, Cécile Ortholan, Christelle Bonnetaud, Céline Coëlle, Jérôme Mouroux, Paul Hofman, Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer Cancer. ,vol. 118, pp. 1726- 1737 ,(2012) , 10.1002/CNCR.26456